Insider · CIK 0001837524

Savill Corrine

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001837524

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-18	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+175K sh	—	—	175,000
2025-02-19	CGEMCullinan Therapeutics, Inc.A Award	Chief Business Officer	AAward	+37.5K sh	—	—	240,990
2025-02-19	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+75K sh	—	—	75,000
2024-02-22	CGEMCullinan Therapeutics, Inc.A Award	Chief Business Officer	AAward	+37.5K sh	—	—	203,490
2024-02-22	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+75K sh	—	—	75,000
2024-02-01	CGEMCullinan Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+40K sh	$4.30	+$172K	205,990
2024-02-01	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−40K sh	$16.18	−$647K	165,990
2024-02-01	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−40K sh	—	—	70,331
2024-01-29	CGEMCullinan Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+40K sh	$4.30	+$172K	205,990
2024-01-29	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−40K sh	$14.09	−$564K	165,990
2024-01-29	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−14K sh	—	—	0
2024-01-29	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−26K sh	—	—	110,331
2024-01-23	CGEMCullinan Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+21.3K sh	$4.30	+$91.7K	187,306
2024-01-23	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−21.3K sh	$12.46	−$266K	165,990
2024-01-23	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−21.3K sh	—	—	13,997
2024-01-22	CGEMCullinan Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+14.6K sh	$4.30	+$62.6K	184,674
2024-01-22	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−14.6K sh	$12.18	−$177K	170,115
2024-01-22	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,125 sh	$12.02	−$49.6K	165,990
2024-01-22	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−14.6K sh	—	—	35,313
2023-02-17	CGEMCullinan Therapeutics, Inc.A Award	Chief Business Officer	AAward	+20.5K sh	—	—	170,115
2023-02-17	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+41K sh	—	—	41,000
2022-07-19	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−15K sh	$15.22	−$228K	149,615
2022-07-18	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,042 sh	$15.06	−$75.9K	164,573
2022-07-11	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−39.8K sh	$13.33	−$531K	169,815
2022-07-11	CGEMCullinan Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−200 sh	$13.85	−$2,770	169,615
2022-02-11	CGEMCullinan Therapeutics, Inc.A Award	Chief Business Officer	AAward	+16.5K sh	—	—	209,615
2022-02-11	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+33K sh	—	—	33,000

Recent filings

Accepted (ET)
Feb 194
Savill Corrine0001193125-26-059638
SEC(opens sec.gov)
Feb 214
Savill Corrine0000950170-25-025031
SEC(opens sec.gov)
Feb 234
Savill Corrine0000950170-24-019463
SEC(opens sec.gov)
Feb 24
Savill Corrine0000950170-24-010975
SEC(opens sec.gov)
Jan 304
Savill Corrine0000950170-24-009047
SEC(opens sec.gov)
Jan 244
Savill Corrine0000950170-24-007032
SEC(opens sec.gov)
Feb 214
Savill Corrine0000899243-23-005735
SEC(opens sec.gov)

Companies

Cullinan Therapeutics, Inc.Chief Business OfficerCGEM

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142